Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review

Cancer
Elie A AklHolger J Schünemann

Abstract

The authors compared the relative efficacy and safety of low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. By using Cochrane methodology for systematic reviews, separate meta-analyses were conducted for subgroups of patients with and without cancer, and relative risks (RRs) were compared for statistical significance. The methodologic quality for each outcome was assessed by using the Grading of Recommendations Assessment, Development, and Evaluation approach. LMWH reduced mortality significantly compared with UFH in patients with cancer (RR of 0.71; 95% confidence interval [95% CI], 0.52-0.98 [moderate-quality evidence]) but not in patients without cancer (RR of 0.97; 95% CI, 0.65-1.46 [low-quality evidence]). However, the difference in the RR for the 2 subgroups did not reach statistical significance (P = .113). The difference between LMWH and UFH in the effect on recurrent VTE was not statistically significant in the subgroup with cancer (RR of 0.78; 95% CI, 0.29-2.08 [low-quality evidence]), in the subgroup without cancer (RR of 0.94; 95% CI, 0.60-1.46 [low-quality evidence]), or between the 2 subgroups (P =...Continue Reading

References

Jan 1, 1993·Statistical Methods in Medical Research·J L Fleiss
Sep 4, 1997·The New England Journal of Medicine·UNKNOWN Columbus InvestigatorsR Baildon
Jun 3, 2004·Annals of Internal Medicine·Harry R BüllerUNKNOWN Matisse Investigators

❮ Previous
Next ❯

Citations

Mar 17, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Myra F BarginearDaniel R Budman
Feb 23, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nadia HindiEnrique Espinosa
Feb 19, 2011·Journal of Thrombosis and Thrombolysis·Michael B Streiff
Jan 19, 2011·Current Treatment Options in Cardiovascular Medicine·Andrea Piccioli, Paolo Prandoni
Jun 15, 2013·Journal of Gastrointestinal Cancer·Faruk TasDerya Duranyildiz
Aug 2, 2011·Journal of Medicinal Chemistry·Rami A Al-HoraniUmesh R Desai
Jan 16, 2010·Journal of Hematology & Oncology·Francisco Robert
Oct 10, 2009·Journal of Experimental & Clinical Cancer Research : CR·Maddalena BarbaPaola Muti
Jan 1, 2012·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·William M Semchuk, Catherine Sperlich
Oct 6, 2011·Hämostaseologie·A Falanga, L Russo
Jul 16, 2014·Seminars in Oncology·Corinne FrereDominique Farge
Nov 19, 2014·CNS Drugs·Riccardo SoffiettiRoberta Rudà
Oct 15, 2011·The Journal of Supportive Oncology·Jessica McCannon, Jennifer Temel
Sep 10, 2010·Seminars in Vascular Surgery·Andrea T East, Thomas W Wakefield
May 15, 2010·Thrombosis Research·Dominique FargeUNKNOWN Groupe Francophone Thrombose et Cancer (GFTC)
Sep 12, 2009·Thrombosis Research·Davide ImbertiUNKNOWN Italian Society for Thrombosis and Haemostasis
Oct 10, 2008·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Sue Rhodes, Sarah Bond
Sep 9, 2008·Seminars in Vascular Surgery·Timothy K Liem, Thomas G Deloughery
Feb 15, 2015·Journal of the American Medical Directors Association·Serena GranzieraGiuseppe Sergi
Apr 3, 2016·Disease-a-month : DM·Harry E FuentesJoseph A Caprini
Dec 4, 2012·Respiratory Medicine·Faruk TasDerya Duranyildiz
Sep 1, 2014·European Heart Journal·Stavros V KonstantinidesUNKNOWN Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
Aug 5, 2015·Biochemical Pharmacology·Daniel Bastian PfankuchenGerd Bendas
Mar 20, 2016·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Elna M MasudaRobert L Kistner
Apr 29, 2011·American Journal of Infection Control·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Mar 7, 2015·Thrombosis Research·Massimo FranchiniGiuseppe Lippi
Mar 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles A SchifferMark Levine
Apr 22, 2011·Journal of Pharmacy Practice·Joanna Maudlin Pangilinan
Nov 24, 2012·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Saul N WeingartJean M Connors
Jun 18, 2010·The Cochrane Database of Systematic Reviews·Che Anuar Che YaakobJacqueline J Ho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.